Sort by
Refine Your Search
-
Listed
-
Field
-
. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and
-
medicine, vascular biology, bioengineering, and data science, Dr. Chen leads an active research program focused on noncoding RNAs and endothelial stress response. Her team integrates innovative high
-
the Department of Hematological Malignancies Translational Science, Department of Pediatrics, and Gehr Family Center for Leukemia Research. Dr. Li's research program is supported by several NIH (R01s), American
-
bioinformatics or are interested in learning computational techniques related to tumor immunology, there is an opportunity to work on a project with Dr. Nicholas Banovich from TGen. As a successful candidate, you
-
. We are looking for a highly motivated candidate with a PhD and/or MD degree interested in using novel biological and computational methods with the aim of developing novel strategies to improve CAR T
-
). · Experience in computational biology, bioinformatics, transcriptomic, proteomic, data analysis (highly preferred). City of Hope is an equal opportunity employer. To learn more about our commitment to diversity
-
director of the Prostate Cancer Research Program in the comprehensive cancer center. Dr. Sun’s research interest focuses on the molecular mechanisms underlying transcriptional control and cell signaling in
-
synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and their